NCT06740578View on ClinicalTrials.gov

Evaluation of the Added Clinical Value of Donor-derived Cell-free DNA for the Monitoring of Cardiac Allograft Rejection.

CompletedOBSERVATIONAL

Enrollment

320

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions

Heart TransplantationRejection Heart Transplant

Trial Locations (2)

75013

Pitié-Salpêtrière Hospital, Paris

75015

Georges Pompidou European Hospital, Paris

All Listed Sponsors

lead

Paris Translational Research Center for Organ Transplantation

OTHER

NCT06740578 - Evaluation of the Added Clinical Value of Donor-derived Cell-free DNA for the Monitoring of Cardiac Allograft Rejection. | Biotech Hunter | Biotech Hunter